These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15364586)

  • 1. The disintegrin echistatin stabilizes integrin alphaIIbbeta3's open conformation and promotes its oligomerization.
    Hantgan RR; Stahle MC; Connor JH; Lyles DS; Horita DA; Rocco M; Nagaswami C; Weisel JW; McLane MA
    J Mol Biol; 2004 Oct; 342(5):1625-36. PubMed ID: 15364586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entropy drives integrin alphaIIbbeta3:echistatin binding--evidence from surface plasmon resonance spectroscopy.
    Hantgan RR; Stahle MC; Horita DA
    Biochemistry; 2008 Mar; 47(9):2884-92. PubMed ID: 18237139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of a fibrinogen mimetic stabilizes integrin alphaIIbbeta3's open conformation.
    Hantgan RR; Rocco M; Nagaswami C; Weisel JW
    Protein Sci; 2001 Aug; 10(8):1614-26. PubMed ID: 11468358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ligand-mimetic peptides Arg-Gly-Asp-X (X = Phe, Trp, Ser) on alphaIIbbeta3 integrin conformation and oligomerization.
    Hantgan RR; Paumi C; Rocco M; Weisel JW
    Biochemistry; 1999 Nov; 38(44):14461-74. PubMed ID: 10545168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site.
    Marcinkiewicz C; Vijay-Kumar S; McLane MA; Niewiarowski S
    Blood; 1997 Aug; 90(4):1565-75. PubMed ID: 9269775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin priming dynamics: mechanisms of integrin antagonist-promoted alphaIIbbeta3:PAC-1 molecular recognition.
    Hantgan RR; Stahle MC
    Biochemistry; 2009 Sep; 48(35):8355-65. PubMed ID: 19640007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin alphaIIbbeta3:ligand interactions are linked to binding-site remodeling.
    Hantgan RR; Stahle MC; Connor JH; Horita DA; Rocco M; McLane MA; Yakovlev S; Medved L
    Protein Sci; 2006 Aug; 15(8):1893-906. PubMed ID: 16877710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of alphaIIbbeta3 antagonism by savignygrin and its implications for the evolution of anti-hemostatic strategies in soft ticks.
    Mans BJ; Neitz AW
    Insect Biochem Mol Biol; 2004 Jun; 34(6):573-84. PubMed ID: 15147758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists.
    Hantgan RR; Stahle MC; Connor JH; Connor RF; Mousa SA
    J Thromb Haemost; 2007 Mar; 5(3):542-50. PubMed ID: 17166246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins.
    McLane MA; Vijay-Kumar S; Marcinkiewicz C; Calvete JJ; Niewiarowski S
    FEBS Lett; 1996 Aug; 391(1-2):139-43. PubMed ID: 8706902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin clustering mechanisms explored with a soluble alphaIIbbeta3 ectodomain construct.
    Hantgan RR; Gibbs W; Stahle MC; Aster RH; Peterson JA
    Biochim Biophys Acta; 2004 Jul; 1700(1):19-25. PubMed ID: 15210121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tirofiban blocks platelet adhesion to fibrin with minimal perturbation of GpIIb/IIIa structure.
    Hantgan RR; Stahle MC; Jerome WG; Nagaswami C; Weisel JW
    Thromb Haemost; 2002 May; 87(5):910-7. PubMed ID: 12038797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positional importance of Pro53 adjacent to the Arg49-Gly50-Asp51 sequence of rhodostomin in binding to integrin alphaIIbbeta3.
    Chang CP; Chang JC; Chang HH; Tsai WJ; Lo SJ
    Biochem J; 2001 Jul; 357(Pt 1):57-64. PubMed ID: 11415436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergy site of fibronectin is required for strong interaction with the platelet integrin alphaIIbbeta3.
    Chada D; Mather T; Nollert MU
    Ann Biomed Eng; 2006 Oct; 34(10):1542-52. PubMed ID: 16933105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential recognition of snake venom proteins expressing specific Arg-Gly-Asp (RGD) sequence motifs by wild-type and variant integrin alphaIIbbeta3: further evidence for distinct sites of RGD ligand recognition exhibiting negative allostery.
    Rahman S; Flynn G; Aitken A; Patel Y; Hussain F; Lu X; Loftus JC; French D; Wijelath E; Strand K; Savidge GF
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):701-9. PubMed ID: 10642531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AFM imaging of ligand binding to platelet integrin alphaIIbbeta3 receptors reconstituted into planar lipid bilayers.
    Hussain MA; Agnihotri A; Siedlecki CA
    Langmuir; 2005 Jul; 21(15):6979-86. PubMed ID: 16008412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic regulation of fibrinogen: integrin αIIbβ3 binding.
    Hantgan RR; Stahle MC; Lord ST
    Biochemistry; 2010 Nov; 49(43):9217-25. PubMed ID: 20828133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation.
    Rahman S; Aitken A; Flynn G; Formstone C; Savidge GF
    Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):247-57. PubMed ID: 9761721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular engineering of an EGFP/disintegrin-based integrin marker.
    Butera D; Piazza RM; McLane MA; Chammas R; da Silva AM
    Toxicon; 2005 Aug; 46(2):178-84. PubMed ID: 15922386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to purified integrin alphaIIbbeta3: evidence for a common binding site for cyclic arginyl-glycinyl-aspartic acid peptides and nonpeptides.
    Wong A; Hwang SM; Johanson K; Samanen J; Bennett D; Landvatter SW; Chen W; Heys JR; Ali FE; Ku TW; Bondinell W; Nichols AJ; Powers DA; Stadel JM
    J Pharmacol Exp Ther; 1998 Apr; 285(1):228-35. PubMed ID: 9536015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.